Livzon Pharmaceutical Group Inc. (SHE:000513)

China flag China · Delayed Price · Currency is CNY
36.49
-0.26 (-0.71%)
Jun 6, 2025, 3:04 PM CST
-8.11%
Market Cap 29.74B
Revenue (ttm) 11.75B
Net Income (ttm) 2.09B
Shares Out 892.78M
EPS (ttm) 2.29
PE Ratio 15.90
Forward PE 14.65
Dividend 1.10 (2.99%)
Ex-Dividend Date Jul 8, 2024
Volume 5,990,717
Average Volume 7,937,574
Open 36.15
Previous Close 36.75
Day's Range 36.15 - 36.85
52-Week Range 32.94 - 44.72
Beta 0.34
RSI 55.98
Earnings Date Aug 20, 2025

About SHE:000513

Livzon Pharmaceutical Group Inc. researches, develops, produces, exports, and sells pharmaceutical products, and active pharmaceutical ingredients and intermediates in the People’s Republic of China. The company offers drug preparation products, including Ilaprazole enteric coated tablets to treat duodenal ulcers and reflux esophagitis; Laprazole sodium for injection to treat peptic ulcer hemorrhage; Leuprorelin Acetate Microspheres for injection to treat endometriosis, hysteromyoma, premenopausal breast and prostate cancer, and central precoci... [Read more]

Sector Healthcare
Founded 1985
Employees 9,067
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000513
Full Company Profile

Financial Performance

In 2024, SHE:000513's revenue was 11.81 billion, a decrease of -4.97% compared to the previous year's 12.43 billion. Earnings were 2.06 billion, an increase of 5.50%.

Financial Statements

News

There is no news available yet.